5299 篇
13868 篇
408774 篇
16079 篇
9269 篇
3869 篇
6464 篇
1238 篇
72401 篇
37108 篇
12060 篇
1619 篇
2821 篇
3387 篇
640 篇
1229 篇
1965 篇
4866 篇
3821 篇
5293 篇
全球特发性肺纤维化市场报告(2016-2020年)
Global Idiopathic Pulmonary Fibrosis Market 2016-2020
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Disease overview
Understanding the disease
Pathogenesis
Signs and symptoms
Diagnosis
Management
Epidemiology
PART 06: Pipeline analysis
Lebrikizumab
Tipelukast
Tralokinumab
FG-3019
Simtuzumab
BMS-986020
AF-219
SAR156597
BG00011
PRM-151
PBI-4050
PART 07: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 08: Market segmentation by ROA
Oral
Parenteral
PART 09: Market segmentation by drug class
Systemic corticosteroids
Immunosuppressants
Tyrosine kinase inhibitors
Anti-fibrotic agents
PART 10: Geographical segmentation
Global idiopathic pulmonary fibrosis market by
geographical segmentation 2015-2020
Idiopathic pulmonary fibrosis market in Americas
Idiopathic pulmonary fibrosis market in EMEA
Idiopathic pulmonary fibrosis market in APAC
PART 11: Market drivers
Special regulatory designations for pipeline candidates
Growth in patient population
Unmet medical needs
PART 12: Impact of drivers
PART 13: Market challenges
Unknown disease etiology
Lack of proper diagnosis
Increased use of off-label and alternative therapies
PART 14: Impact of drivers and challenges
PART 15: Market trends
Patient assistance programs
Increase in M&A
Rise in public awareness
PART 16: Vendor landscape
Competitive scenario
Market share analysis 2015
Baxter International
Boehringer Ingelheim
F Hoffmann-La Roche
Prometheus Laboratories
Other prominent vendors
PART 17: Appendix
List of abbreviations
PART 18: Explore Technavio